Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Sepsis

Free Subscription Articles published in Intensive Care Med Retrieve available abstracts of 88 articles: HTML format

Single Articles

May 2024
1. LEONE M, Nielsen ND, Russell L
   Ten tips on sepsis-induced thrombocytopenia.
   Intensive Care Med. 2024 May 13. doi: 10.1007/s00134-024-07478.
   PubMed    
   
   
   
2. ZIMMERMANN T, Brealey D, Singer M
   Diagnosing sepsis: where we're at and where we're going.
   Intensive Care Med. 2024 May 2. doi: 10.1007/s00134-024-07428.
   PubMed    
   
   
   
3. AHLSTEDT C, Sivapalan P, Kriz M, Jacobson G, et al
   Effects of restrictive fluid therapy on the time to resolution of hyperlactatemia in ICU patients with septic shock. A secondary post hoc analysis of the CLASSIC randomized trial.
   Intensive Care Med. 2024;50:678-686.
   PubMed     Abstract available
   
   
   April 2024
4. CHAI MG, Tu Q, Cotta MO, Bauer MJ, et al
   Correction: Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.
   Intensive Care Med. 2024 Apr 2. doi: 10.1007/s00134-024-07393.
   PubMed    
   
   
   
5. ZHAO Y, Zang B, Wang Q
   The effectiveness of alkaline phosphatase in sepsis-associated acute kidney injury.
   Intensive Care Med. 2024 Apr 2. doi: 10.1007/s00134-024-07392.
   PubMed    
   
   
   
6. HERNANDEZ G, Carmona P, Ait-Oufella H
   Monitoring capillary refill time in septic shock.
   Intensive Care Med. 2024;50:580-582.
   PubMed    
   
   
   
7. KATTAN E, Ibarra-Estrada M, Jung C
   Knowing the ropes of vasopressor dosing: a focus on norepinephrine.
   Intensive Care Med. 2024;50:587-589.
   PubMed    
   
   
   March 2024
8. CHAI GG, Tu Q, Cotta MO, Bauer MJ, et al
   Achievement of therapeutic antibiotic exposures using Bayesian dosing software in critically unwell children and adults with sepsis.
   Intensive Care Med. 2024 Mar 13. doi: 10.1007/s00134-024-07353.
   PubMed     Abstract available
   
   
   
9. PICKKERS P, Angus DC, Bass K, Bellomo R, et al
   Correction: Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
   Intensive Care Med. 2024 Mar 4. doi: 10.1007/s00134-024-07357.
   PubMed    
   
   
   
10. AHLSTROM B, Larsson IM, Strandberg G, Lipcsey M, et al
    Association of sepsis with long-term mortality and causes of death in the Swedish intensive care cohort.
    Intensive Care Med. 2024 Mar 4. doi: 10.1007/s00134-024-07370.
    PubMed    
    
    
    
11. DE BACKER D, Hajjar L, Monnet X
    Vasoconstriction in septic shock.
    Intensive Care Med. 2024;50:459-462.
    PubMed    
    
    
    
12. KREITMANN L, Helms J, Martin-Loeches I, Salluh J, et al
    ICU-acquired infections in immunocompromised patients.
    Intensive Care Med. 2024;50:332-349.
    PubMed     Abstract available
    
    
    January 2024
13. PROWLE JR, Bagshaw SM, Forni LG
    Tackling sepsis-associated AKI: are there any chances of REVIVAL with new approaches?
    Intensive Care Med. 2024 Jan 10. doi: 10.1007/s00134-023-07294.
    PubMed    
    
    
    
14. PICKKERS P, Angus DC, Bass K, Bellomo R, et al
    Phase-3 trial of recombinant human alkaline phosphatase for patients with sepsis-associated acute kidney injury (REVIVAL).
    Intensive Care Med. 2024 Jan 3. doi: 10.1007/s00134-023-07271.
    PubMed     Abstract available
    
    
    
15. ZAMPIERI FG, Machado FR, Veiga VC, Azevedo LCP, et al
    Determinants of fluid use and the association between volume of fluid used and effect of balanced solutions on mortality in critically ill patients: a secondary analysis of the BaSICS trial.
    Intensive Care Med. 2024;50:79-89.
    PubMed     Abstract available
    
    
    November 2023
16. BALIK M, Maly M, Brozek T, Rulisek J, et al
    Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial.
    Intensive Care Med. 2023;49:1283-1292.
    PubMed     Abstract available
    
    
    October 2023
17. FOWLER C, Scordo M, Chawla S
    The EAS(E)IX of predicting sepsis after allogeneic hematopoietic cell transplantation.
    Intensive Care Med. 2023 Oct 24. doi: 10.1007/s00134-023-07242.
    PubMed    
    
    
    
18. VAN AMSTEL RBE, Kennedy JN, Scicluna BP, Bos LDJ, et al
    Uncovering heterogeneity in sepsis: a comparative analysis of subphenotypes.
    Intensive Care Med. 2023 Oct 18. doi: 10.1007/s00134-023-07239.
    PubMed     Abstract available
    
    
    
19. ZHANG Z, Chen L, Liu X, Yang J, et al
    Exploring disease axes as an alternative to distinct clusters for characterizing sepsis heterogeneity.
    Intensive Care Med. 2023 Oct 4. doi: 10.1007/s00134-023-07226.
    PubMed     Abstract available
    
    
    September 2023
20. WHITE KC, Laupland KB, Tabah A, Ramanan M, et al
    Details and the devil within: the case of sepsis associated AKI. Author's reply.
    Intensive Care Med. 2023 Sep 10. doi: 10.1007/s00134-023-07209.
    PubMed    
    
    
    August 2023
21. GOMEZ H, Zarbock A
    Details and the devil within - the case of sepsis associated acute kidney injury.
    Intensive Care Med. 2023 Aug 31. doi: 10.1007/s00134-023-07204.
    PubMed    
    
    
    
22. WHITE KC, Laupland KB, Tabah A, Ramanan M, et al
    Clinical implications of urine output-based sepsis-associated acute kidney injury. Author's reply.
    Intensive Care Med. 2023 Aug 28. doi: 10.1007/s00134-023-07205.
    PubMed    
    
    
    
23. CLAURE-DEL GRANADO R, James MT, Legrand M
    Tackling sepsis-associated acute kidney injury using routinely collected data.
    Intensive Care Med. 2023 Aug 28. doi: 10.1007/s00134-023-07200.
    PubMed    
    
    
    
24. GIAMARELLOS-BOURBOULIS EJ, Zinkernagel AS, De Robertis E, Azoulay E, et al
    Correction: Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control.
    Intensive Care Med. 2023 Aug 24. doi: 10.1007/s00134-023-07197.
    PubMed    
    
    
    
25. KORELL F, DeFilipp Z, Schreck N, Luft T, et al
    Validation of pre-conditioning EASIX for prediction of sepsis after allogeneic stem cell transplantation.
    Intensive Care Med. 2023 Aug 23. doi: 10.1007/s00134-023-07193.
    PubMed    
    
    
    
26. KASUGAI D, Nakashima T, Goto T
    Clinical implications of urine output-based sepsis-associated acute kidney injury.
    Intensive Care Med. 2023 Aug 21. doi: 10.1007/s00134-023-07190.
    PubMed    
    
    
    
27. GIAMARELLOS-BOURBOULIS EJ, Zinkernagel AS, De Robertis E, Azoulay E, et al
    Sepsis, a call for inclusion in the work plan of the European Center for Disease Prevention and Control.
    Intensive Care Med. 2023 Aug 1. doi: 10.1007/s00134-023-07127.
    PubMed    
    
    
    July 2023
28. REILLY JP, Zhao Z, Shashaty MGS, Koyama T, et al
    Exposure to ambient air pollutants and acute respiratory distress syndrome risk in sepsis.
    Intensive Care Med. 2023 Jul 20. doi: 10.1007/s00134-023-07148.
    PubMed     Abstract available
    
    
    
29. WHITE KC, Serpa-Neto A, Hurford R, Clement P, et al
    Sepsis-associated acute kidney injury in the intensive care unit: incidence, patient characteristics, timing, trajectory, treatment, and associated outcomes. A multicenter, observational study.
    Intensive Care Med. 2023 Jul 11. doi: 10.1007/s00134-023-07138.
    PubMed     Abstract available
    
    
    
30. KJAER MN, Meyhoff TS, Sivapalan P, Granholm A, et al
    Long-term effects of restriction of intravenous fluid in adult ICU patients with septic shock.
    Intensive Care Med. 2023;49:820-830.
    PubMed     Abstract available
    
    
    June 2023
31. ZHANG C, Zhang X, Sun Z, Liu X, et al
    MetaSepsisBase: a biomarker database for systems biological analysis and personalized diagnosis of heterogeneous human sepsis.
    Intensive Care Med. 2023 Jun 17. doi: 10.1007/s00134-023-07126.
    PubMed    
    
    
    
32. BRUNO RR, Wollborn J, Fengler K, Flick M, et al
    Direct assessment of microcirculation in shock: a randomized-controlled multicenter study.
    Intensive Care Med. 2023;49:645-655.
    PubMed     Abstract available
    
    
    April 2023
33. BOLDT J, Muller M, Kuhn D, Linke LC, et al
    Retraction Note: Circulating adhesion molecules in the critically ill: A comparison between trauma and sepsis patients.
    Intensive Care Med. 2023 Apr 4. doi: 10.1007/s00134-023-07055.
    PubMed    
    
    
    February 2023
34. MATCHETT G, Moon TS, Stewart JW, Liang L, et al
    Etomidate for endotracheal intubation in sepsis. Author's reply.
    Intensive Care Med. 2023 Feb 23. doi: 10.1007/s00134-023-06987.
    PubMed    
    
    
    
35. TABAH A, Buetti N, Staiquly Q, Ruckly S, et al
    Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study.
    Intensive Care Med. 2023 Feb 10:1-13. doi: 10.1007/s00134-022-06944.
    PubMed     Abstract available
    
    
    January 2023
36. KALIMOUTTOU A, Pirracchio R
    Database-based machine learning in sepsis deserves attention. Author's reply.
    Intensive Care Med. 2023 Jan 10. doi: 10.1007/s00134-022-06972.
    PubMed    
    
    
    
37. MOHR NM, Faine B
    Etomidate for endotracheal intubation in sepsis.
    Intensive Care Med. 2023 Jan 4. doi: 10.1007/s00134-022-06962.
    PubMed    
    
    
    
38. HU W, Yang M, Chen H
    Database-based machine learning in sepsis deserves attention.
    Intensive Care Med. 2023 Jan 2. doi: 10.1007/s00134-022-06961.
    PubMed    
    
    
    
39. POVOA P, Coelho L, Dal-Pizzol F, Ferrer R, et al
    How to use biomarkers of infection or sepsis at the bedside: guide to clinicians.
    Intensive Care Med. 2023 Jan 2:1-12. doi: 10.1007/s00134-022-06956.
    PubMed     Abstract available
    
    
    November 2022
40. KALIMOUTTOU A, Lerner I, Cheurfa C, Jannot AS, et al
    Machine-learning-derived sepsis bundle of care.
    Intensive Care Med. 2022 Nov 29. doi: 10.1007/s00134-022-06928.
    PubMed     Abstract available
    
    
    
41. DE PASCALE G, Antonelli M, Deschepper M, Arvaniti K, et al
    Poor timing and failure of source control are risk factors for mortality in critically ill patients with secondary peritonitis.
    Intensive Care Med. 2022;48:1593-1606.
    PubMed     Abstract available
    
    
    September 2022
42. BHAVANI SV, Semler M, Qian ET, Verhoef PA, et al
    Development and validation of novel sepsis subphenotypes using trajectories of vital signs.
    Intensive Care Med. 2022 Sep 24. pii: 10.1007/s00134-022-06890.
    PubMed     Abstract available
    
    
    
43. COUR M, Klouche K, Souweine B, Quenot JP, et al
    Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06872.
    PubMed     Abstract available
    
    
    
44. RUSSELL JA, Meyer NJ, Walley KR
    Use of Mendelian randomization to better understand and treat sepsis.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06778.
    PubMed    
    
    
    
45. DE WAELE JJ, Girardis M, Martin-Loeches I
    Source control in the management of sepsis and septic shock.
    Intensive Care Med. 2022 Sep 14. pii: 10.1007/s00134-022-06852.
    PubMed    
    
    
    August 2022
46. YOUNG PJ, Lamontagne F, Fujii T
    Vitamin C in sepsis.
    Intensive Care Med. 2022 Aug 12. pii: 10.1007/s00134-022-06822.
    PubMed    
    
    
    July 2022
47. LUKASZEWSKI RA, Jones HE, Gersuk VH, Russell P, et al
    Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures.
    Intensive Care Med. 2022 Jul 13. pii: 10.1007/s00134-022-06769.
    PubMed     Abstract available
    
    
    June 2022
48. BLOOS F, Held J, Kluge S, Simon P, et al
    (1 --> 3)-beta-D-Glucan-guided antifungal therapy in adults with sepsis: the CandiSep randomized clinical trial.
    Intensive Care Med. 2022 Jun 16. pii: 10.1007/s00134-022-06733.
    PubMed     Abstract available
    
    
    
49. MEYNAAR IA, van Rijn S, Ottens TH, van Burgel ND, et al
    Increased risk of central line-associated bloodstream infection in COVID-19 patients associated with dexamethasone but not with interleukin antagonists.
    Intensive Care Med. 2022 Jun 7. pii: 10.1007/s00134-022-06750.
    PubMed    
    
    
    April 2022
50. KORELL F, Schreck N, Muller-Tidow C, Dreger P, et al
    Pre-transplant EASIX and sepsis after allogeneic stem cell transplantation.
    Intensive Care Med. 2022 Apr 16. pii: 10.1007/s00134-022-06676.
    PubMed    
    
    
    
51. TRAN A, Fernando SM, Rochwerg B, Seymour CW, et al
    Characterizing systematic challenges in sample size determination for sepsis trials.
    Intensive Care Med. 2022 Apr 12. pii: 10.1007/s00134-022-06691.
    PubMed    
    
    
    
52. POOLE D, D'Arrigo S
    Coupled plasma filtration and adsorption for the treatment of septic shock.
    Intensive Care Med. 2022;48:493-495.
    PubMed    
    
    
    March 2022
53. BUIL JB, Schouten JA, Wauters J, van de Hoeven H, et al
    Absence of candidemia in critically ill patients with COVID-19 receiving selective digestive decontamination.
    Intensive Care Med. 2022 Mar 22. pii: 10.1007/s00134-022-06651.
    PubMed    
    
    
    
54. HAGEL S, Bach F, Brenner T, Bracht H, et al
    Correction to: Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
    Intensive Care Med. 2022 Mar 18. pii: 10.1007/s00134-022-06668.
    PubMed    
    
    
    
55. GIJSEN M, Dreesen E, Wauters J, Debaveye Y, et al
    The TARGET trial as a plea for model-informed precision dosing of piperacillin/tazobactam in patients with sepsis.
    Intensive Care Med. 2022 Mar 17. pii: 10.1007/s00134-022-06679.
    PubMed    
    
    
    
56. HAGEL S, Pletz MW, Lehmann T
    Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis. Author's reply.
    Intensive Care Med. 2022 Mar 15. pii: 10.1007/s00134-022-06669.
    PubMed    
    
    
    February 2022
57. YOSHIHIRO S, Taito S
    Concerns about study design and suggestion of additional analysis of therapeutic drug monitoring-guided piperacillin/tazobactam therapy for patients with sepsis.
    Intensive Care Med. 2022 Feb 18. pii: 10.1007/s00134-022-06648.
    PubMed    
    
    
    
58. ZHANG S, Li B, Yi S, He Z, et al
    Goal-directed therapy in sepsis strikes back. Author's reply.
    Intensive Care Med. 2022 Feb 14. pii: 10.1007/s00134-022-06633.
    PubMed    
    
    
    
59. ANGRIMAN F, Rosella LC, Lawler PR, Ko DT, et al
    Sepsis hospitalization and risk of subsequent cardiovascular events in adults: a population-based matched cohort study.
    Intensive Care Med. 2022 Feb 10. pii: 10.1007/s00134-022-06634.
    PubMed     Abstract available
    
    
    
60. HAGEL S, Bach F, Brenner T, Bracht H, et al
    Effect of therapeutic drug monitoring-based dose optimization of piperacillin/tazobactam on sepsis-related organ dysfunction in patients with sepsis: a randomized controlled trial.
    Intensive Care Med. 2022 Feb 1. pii: 10.1007/s00134-021-06609.
    PubMed     Abstract available
    
    
    
61. BAKKER J, Kattan E, Annane D, Castro R, et al
    Current practice and evolving concepts in septic shock resuscitation.
    Intensive Care Med. 2022;48:148-163.
    PubMed     Abstract available
    
    
    January 2022
62. CHEN HH, Lin CH, Wu CL, Chao WC, et al
    Incidence and risk factors of mental illness among the spouses of patients with sepsis: a population-based cohort study.
    Intensive Care Med. 2022 Jan 25. pii: 10.1007/s00134-022-06624.
    PubMed    
    
    
    
63. YU K, Zhang S, Chen N, Chen M, et al
    Critical care ultrasound goal-directed versus early goal-directed therapy in septic shock.
    Intensive Care Med. 2022;48:121-123.
    PubMed    
    
    
    December 2021
64. PETERS-SENGERS H, Butler JM, Uhel F, Schultz MJ, et al
    Source-specific host response and outcomes in critically ill patients with sepsis: a prospective cohort study.
    Intensive Care Med. 2021 Dec 13. pii: 10.1007/s00134-021-06574.
    PubMed     Abstract available
    
    
    November 2021
65. FUJII T, Salanti G, Belletti A, Bellomo R, et al
    Effect of adjunctive vitamin C, glucocorticoids, and vitamin B1 on longer-term mortality in adults with sepsis or septic shock: a systematic review and a component network meta-analysis.
    Intensive Care Med. 2021 Nov 9. pii: 10.1007/s00134-021-06558.
    PubMed     Abstract available
    
    
    
66. SKURZAK S, Gallo M, Lavezzo B, Iannandrea S, et al
    Goal-directed therapy in sepsis strikes back.
    Intensive Care Med. 2021 Nov 8. pii: 10.1007/s00134-021-06569.
    PubMed    
    
    
    
67. LATERRE PF, Pickkers P, Marx G, Wittebole X, et al
    Safety and tolerability of non-neutralizing adrenomedullin antibody adrecizumab (HAM8101) in septic shock patients: the AdrenOSS-2 phase 2a biomarker-guided trial.
    Intensive Care Med. 2021;47:1284-1294.
    PubMed     Abstract available
    
    
    
68. GARBERO E, Livigni S, Ferrari F, Finazzi S, et al
    High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial.
    Intensive Care Med. 2021;47:1303-1311.
    PubMed     Abstract available
    
    
    
69. WENDEL GARCIA PD, Hilty MP, Held U, Kleinert EM, et al
    Cytokine adsorption in severe, refractory septic shock.
    Intensive Care Med. 2021;47:1334-1336.
    PubMed    
    
    
    October 2021
70. STAHL K, Wendel-Garcia PD, Bode C, David S, et al
    Unraveling the secret of re-balancing homeostasis in sepsis: a critical view on extracorporeal blood purification modalities.
    Intensive Care Med. 2021 Oct 28. pii: 10.1007/s00134-021-06560.
    PubMed    
    
    
    
71. SATO R, Hasegawa D, Dugar S
    Do we have sufficient evidence to support the use of inotropes in patients with sepsis?
    Intensive Care Med. 2021 Oct 26. pii: 10.1007/s00134-021-06564.
    PubMed    
    
    
    
72. EVANS L, Rhodes A, Alhazzani W, Antonelli M, et al
    Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021.
    Intensive Care Med. 2021 Oct 2. pii: 10.1007/s00134-021-06506.
    PubMed    
    
    
    September 2021
73. LIEBCHEN U, Scharf C, Zoller M, Weinelt F, et al
    No clinically relevant removal of meropenem by cytokine adsorber CytoSorb((R)) in critically ill patients with sepsis or septic shock.
    Intensive Care Med. 2021 Sep 14. pii: 10.1007/s00134-021-06487.
    PubMed    
    
    
    
74. COHEN J, Blumenthal A, Cuellar-Partida G, Evans DM, et al
    The relationship between adrenocortical candidate gene expression and clinical response to hydrocortisone in patients with septic shock.
    Intensive Care Med. 2021;47:974-983.
    PubMed     Abstract available
    
    
    August 2021
75. SWEENEY TE, Wong HR
    Transcriptional markers in response to hydrocortisone in sepsis in ADRENAL: a step toward precision medicine.
    Intensive Care Med. 2021 Aug 10. pii: 10.1007/s00134-021-06504.
    PubMed    
    
    
    
76. KOSYAKOVSKY LB, Angriman F, Katz E, Adhikari NK, et al
    Association between sepsis survivorship and long-term cardiovascular outcomes in adults: a systematic review and meta-analysis.
    Intensive Care Med. 2021 Aug 9. pii: 10.1007/s00134-021-06479.
    PubMed     Abstract available
    
    
    July 2021
77. 
    Monocyte distribution width as a biomarker of resistance to corticosteroids in patients with sepsis: the MOCORSEP observational study.
    Intensive Care Med. 2021 Jul 27. pii: 10.1007/s00134-021-06478.
    PubMed    
    
    
    
78. 
    Reducing the global burden of sepsis: a positive legacy for the COVID-19 pandemic?
    Intensive Care Med. 2021;47:733-736.
    PubMed    
    
    
    May 2021
79. LITTON E, Currie A, Raby E
    Probiotics and sepsis: separating the signal from the noise.
    Intensive Care Med. 2021 May 20. pii: 10.1007/s00134-021-06427.
    PubMed    
    
    
    March 2021
80. PELLEGRINI JAS, Schwarz P, Parolo E, Cremonese RV, et al
    All that glitters is not gold: an unusual presentation of S. aureus sepsis during ECMO.
    Intensive Care Med. 2021 Mar 21. pii: 10.1007/s00134-021-06366.
    PubMed    
    
    
    
81. DAVID S, Bode C, Putensen C, Welte T, et al
    Adjuvant therapeutic plasma exchange in septic shock.
    Intensive Care Med. 2021;47:352-354.
    PubMed    
    
    
    February 2021
82. THOMPSON K, Venkatesh B, Hammond N, Taylor C, et al
    Sex differences in response to adjunctive corticosteroid treatment for patients with septic shock.
    Intensive Care Med. 2021;47:246-248.
    PubMed    
    
    
    January 2021
83. BUETTI N, Ruckly S, de Montmollin E, Reignier J, et al
    COVID-19 increased the risk of ICU-acquired bloodstream infections: a case-cohort study from the multicentric OUTCOMEREA network.
    Intensive Care Med. 2021 Jan 27. pii: 10.1007/s00134-021-06346.
    PubMed     Abstract available
    
    
    July 2020
84. AURIEMMA CL, Delucchi K, Liu KD, Calfee CS, et al
    The attributable mortality of acute respiratory distress syndrome.
    Intensive Care Med. 2020;46:1510-1511.
    PubMed    
    
    
    
85. DE GROOTH HJ, Tuinman PR, Girbes ARJ
    The attributable mortality of acute respiratory distress syndrome.
    Intensive Care Med. 2020;46:1508-1509.
    PubMed    
    
    
    February 2020
86. TIMSIT JF, Ruppe E, Barbier F, Tabah A, et al
    Bloodstream infections in critically ill patients: an expert statement.
    Intensive Care Med. 2020;46:266-284.
    PubMed     Abstract available
    
    
    
87. RELLO J, Campogiani L, Eshwara VK
    Understanding resistance in enterococcal infections.
    Intensive Care Med. 2020;46:353-356.
    PubMed    
    
    
    January 2020
88. ROIMI M, Neuberger A, Shrot A, Paul M, et al
    Early diagnosis of bloodstream infections in the intensive care unit using machine-learning algorithms.
    Intensive Care Med. 2020 Jan 7. pii: 10.1007/s00134-019-05876.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Sepsis is free of charge.